By Colin Kellaher

 

Boston Scientific Corp. on Tuesday said it agreed to buy the 84% of Devoro Medical Inc. it doesn't already own for $269 million and up to $67 million in potential clinical and regulatory milestone payments.

The Marlborough, Mass., maker of medical devices, which has been an investor in Devoro since 2019, said the acquisition adds the WOLF Thrombectomy platform to its peripheral interventions portfolio.

The company said it expects to complete the acquisition by the end of the year.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

September 21, 2021 07:30 ET (11:30 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Oct 2021 to Nov 2021 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Nov 2020 to Nov 2021 Click Here for more Boston Scientific Charts.